SCHEMBL5200569

SCHEMBL5200569

CC(c1ccc(Cl)cc1)C(CNC(=O)C1(c2ccccc2)CC1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 7/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HTT P42858 2/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HDAC4 P56524 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KCNH2 Q12809 1/20 0.42
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202615 0.90 ALDH1A1 (0.43) TRPA1ALDH1A1LMNA
SCHEMBL5203380 0.88 HDAC4 (0.42) TRPA1SMN1; SMN2HTTSLC6A2SLC6A4
SCHEMBL5200440 0.86 ALDH1A1 (0.48) TRPA1SMN1; SMN2ALDH1A1HTTHDAC4
SCHEMBL5201238 0.82 ITGB1 (0.45) SMN1; SMN2ALDH1A1SLC6A2SLC6A4SLC6A3
SCHEMBL5262774 0.80 SLC6A9 (0.54) SMN1; SMN2SLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL5205537 0.80 HDAC4 (0.42) TRPA1SMN1; SMN2ALDH1A1SLC6A2SLC6A4
SCHEMBL4963420 0.79 TRPA1 (0.52) TRPA1SMN1; SMN2ALDH1A1HTTHDAC4
SCHEMBL4963409 0.79 TRPA1 (0.52) TRPA1SMN1; SMN2ALDH1A1HTTHDAC4
SCHEMBL4965217 0.79 SMN1; SMN2 (0.54) TRPA1SMN1; SMN2ALDH1A1HTTHDAC4
SCHEMBL4830008 0.77 CNR1 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP claimed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP claimed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO claimed